Home / Denmark / Novozymes A/S
Novozymes A/S
Short position disclosed on September 30, 2026.
Evolution of the disclosed total
November 1, 2012 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| AQR Capital Management, LLC | 0.59% | new | September 30, 2026 |
In the United States NVZMF (OTC): 998,632 shares sold short on October 15, 2026. FINRA names no fund.
On the other side: the funds that hold Novozymes A/S Titelia
Get the moves on Novozymes A/S by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 2, 2019 | Marshall Wace LLP | 0.79% | September 2, 2019 |
| August 8, 2019 | Marshall Wace LLP | 0.88% | August 8, 2019 |
| August 7, 2019 | Marshall Wace LLP | 0.90% | August 7, 2019 |
| July 4, 2019 | Marshall Wace LLP | 0.80% | July 4, 2019 |
| June 12, 2019 | Marshall Wace LLP | 0.70% | June 12, 2019 |
| June 7, 2019 | Marshall Wace LLP | 0.65% | June 7, 2019 |
| May 29, 2019 | Marshall Wace LLP | 0.70% | May 29, 2019 |
| May 15, 2019 | Marshall Wace LLP | 0.60% | May 15, 2019 |
| May 8, 2019 | Marshall Wace LLP | 0.50% | May 8, 2019 |
| April 11, 2019 | Citadel Europe LLP | 0.46% | April 11, 2019 |
| March 7, 2019 | Citadel Europe LLP | 0.52% | March 7, 2019 |
| March 4, 2019 | Citadel Europe LLP | 0.49% | March 4, 2019 |
| February 20, 2019 | Citadel Europe LLP | 0.50% | February 20, 2019 |
| October 10, 2018 | Marshall Wace LLP | 0.46% | October 10, 2018 |
| October 4, 2018 | Marshall Wace LLP | 0.59% | October 4, 2018 |
| September 14, 2018 | Marshall Wace LLP | 0.68% | September 14, 2018 |
| August 29, 2018 | Marshall Wace LLP | 0.70% | August 29, 2018 |
| July 19, 2018 | Marshall Wace LLP | 0.68% | July 19, 2018 |
| July 12, 2018 | Marshall Wace LLP | 0.70% | July 12, 2018 |
| July 2, 2018 | Marshall Wace LLP | 0.62% | July 2, 2018 |
| June 19, 2018 | Marshall Wace LLP | 0.52% | June 19, 2018 |
| May 17, 2018 | Marshall Wace LLP | 0.49% | May 17, 2018 |
| May 9, 2018 | Marshall Wace LLP | 0.57% | May 9, 2018 |
| May 8, 2018 | Marshall Wace LLP | 0.60% | May 8, 2018 |
| May 4, 2018 | Marshall Wace LLP | 0.59% | May 4, 2018 |
| April 30, 2018 | Marshall Wace LLP | 0.68% | April 30, 2018 |
| April 13, 2018 | Marshall Wace LLP | 0.78% | April 13, 2018 |
| April 6, 2018 | Marshall Wace LLP | 0.87% | April 6, 2018 |
| April 3, 2018 | Marshall Wace LLP | 0.90% | April 3, 2018 |
| March 19, 2018 | Marshall Wace LLP | 0.81% | March 19, 2018 |
| March 6, 2018 | Marshall Wace LLP | 0.70% | March 6, 2018 |
| March 6, 2018 | AQR Capital Management, LLC | 0.49% | March 6, 2018 |
| February 13, 2018 | AQR Capital Management, LLC | 0.58% | February 13, 2018 |
| January 30, 2018 | Marshall Wace LLP | 0.60% | January 30, 2018 |
| January 24, 2018 | AQR Capital Management, LLC | 0.69% | January 24, 2018 |
| January 24, 2018 | Marshall Wace LLP | 0.59% | January 24, 2018 |
| January 10, 2018 | AQR Capital Management, LLC | 0.79% | January 10, 2018 |
| January 8, 2018 | Marshall Wace LLP | 0.69% | January 8, 2018 |
| December 18, 2017 | AQR Capital Management, LLC | 0.89% | December 18, 2017 |
| November 21, 2017 | AQR Capital Management, LLC | 0.99% | November 21, 2017 |
| October 19, 2017 | AQR Capital Management, LLC | 1.09% | October 19, 2017 |
| October 9, 2017 | Marshall Wace LLP | 0.79% | October 9, 2017 |
| September 15, 2017 | Marshall Wace LLP | 0.89% | September 15, 2017 |
| September 14, 2017 | AQR Capital Management, LLC | 1.19% | September 14, 2017 |
| August 23, 2017 | Marshall Wace LLP | 0.90% | August 23, 2017 |
| August 14, 2017 | Marshall Wace LLP | 0.80% | August 14, 2017 |
| July 26, 2017 | Marshall Wace LLP | 0.70% | July 26, 2017 |
| June 15, 2017 | Marshall Wace LLP | 0.60% | June 15, 2017 |
| May 23, 2017 | Marshall Wace LLP | 0.59% | May 23, 2017 |
| May 9, 2017 | Marshall Wace LLP | 0.68% | May 9, 2017 |
Download 227 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Denmark
- GN Store Nord A/S 5.06% of the capital sold short
- Netcompany Group A/S 4.87% of the capital sold short
- Ambu A/S 4.16% of the capital sold short
- Zealand Pharma A/S 3.80% of the capital sold short
- Carlsberg A/S 2.53% of the capital sold short
- Pandora A/S 1.47% of the capital sold short
- Coloplast A/S 1.18% of the capital sold short
- A.P. Møller - Mærsk A/S 1.07% of the capital sold short
- Matas A/S 1.01% of the capital sold short
- Royal Unibrew A/S 0.71% of the capital sold short
- Vestas Wind Systems A/S 0.70% of the capital sold short
- Bavarian Nordic A/S 0.69% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Novozymes A/S, source Finanstilsynet, data as at September 30, 2026, https://www.quivad.com/action/novozymes-a-s?page=4